Comparing the current results to its competitors, Xtant Medical Holdings Inc reported Revenue decrease in the 2 quarter 2026 year on year by -34.73 %, despite the revenue increase by the most of its competitors of 8.51 %, recorded in the same quarter.
Xtant Medical Holdings Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 18.56 %
Xtant Medical Holdings Inc 's Comment on Competition and Industry Peers
The company operates in a competitive market that includes both public and private organizations offering orthobiologics and fixation products. Key competitors include Medtronic plc, Johnson and Johnson, Bioventus Inc., Globus Medical, Inc., OrthoFix Medical Inc., Alphatec Holdings, Inc., Highridge Inc., and SI-Bone Inc., as well as various privately-owned companies. The company also competes with tissue banks that do not provide spinal fixation products, such as AlloSource International, Inc., LifeNet Health, and MTF Biologics. To maintain and enhance its competitive position, the company relies on patents, trademarks, trade secrets, and other proprietary rights, although it acknowledges that patent protection may not fully prevent competitors from developing similar products or challenging its rights.
April 30, 2024
With the advent of continuous innovation, the face of medical treatments is ever-changing. One company making strides in the field is Xtant Medical Holdings, Inc., a prominent global name in the medical technology industry known for its advanced surgical solutions for spinal disorders. Continuing with their role as trailblazers, Xtant recently announced the full commercial launch of two amniotic membrane allografts, SimpliGraft and SimpliMax, from Belgrade, Montana, on April 30, 2024.SimpliGraft and SimpliMax represent a significant evolution in the management of chronic and acute wounds and are set to revolutionize wound care. Their strategic development comes at a time when healthcare stakeholders are incr...
Publicly Traded Peers of Xtant Medical Holdings Inc
Vericel Corporation Share Performance
+18.03%
One Year
Vericel Corporation
Profile
Vericel Corporation's business model revolves around the development and commercialization of innovative cellular therapies for the treatment of severe diseases and conditions.
Integra Lifesciences Holdings Corp's business model revolves around developing, manufacturing, and selling medical devices and instruments to healthcare providers.
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Orthofix Medical Inc is a company that focuses on developing and selling medical devices and orthopedic solutions to healthcare providers and patients.
Sources:
Xtant Medical Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Xtant Medical Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
